How to nail Monthly Investor Updates (FounderU) + Ginkgo Bioworks CEO Jason Kelly | E1239

TL;DR

Ginkgo Bioworks has built a $15 billion business by programming cells and is at the forefront of synthetic biology, exploring biosecurity, gene editing, and the potential applications of synthetic biology in different industries.

Transcript

okay everybody we've got an amazing show for you today i'm really excited because ginkgo biowork ceo and co-founder jason kelly is here to talk about how they've created a 15 billion dollar business by creating basically the aws the cloud computing platform for synthetic biology we get into biosecurity i.e the cova 19 virus and gene editing and the... Read More

Key Insights

• ✊ Ginkgo Bioworks has created a $15 billion business by harnessing the power of DNA to program cells and develop new products and solutions.
• 🎮 Synthetic biology has the potential to revolutionize various industries, from healthcare to manufacturing, by enabling precise control over biological processes.
• *️⃣ Biosecurity is a key consideration in synthetic biology to ensure responsible and safe practices, mitigating potential risks.
• 🖐️ Monthly investor updates play a vital role in building credibility, maintaining investor engagement, and fostering collaboration in the startup ecosystem.

Questions & Answers

Q: How has Ginkgo Bioworks created a $15 billion business in synthetic biology?

Ginkgo Bioworks has leveraged the power of DNA to program cells and create new products and solutions across various industries. Their expertise in synthetic biology has helped them build a successful business.

Q: How does Ginkgo Bioworks ensure biosecurity in their cell programming processes?

Ginkgo Bioworks follows strict biosecurity protocols and works closely with regulatory authorities to ensure responsible and safe practices. They have a robust system in place to prevent the misuse of genetic code and maintain the security of their operations.

Q: What are some potential applications of synthetic biology that Ginkgo Bioworks is exploring?

Ginkgo Bioworks is exploring various applications of synthetic biology, including creating alternative sources of animal products, developing new therapeutic solutions, and improving sustainability in industries such as agriculture and materials.

Q: How important are monthly investor updates for founders?

Monthly investor updates are crucial for founders as they help build credibility, demonstrate progress, and keep investors informed about the company's performance, challenges, and future plans. Regular updates also facilitate collaboration and support from investors.

Summary & Key Takeaways

• Ginkgo Bioworks is a company that programs cells and has created a $15 billion business in synthetic biology by utilizing the power of DNA to develop new products and solutions.

• The company is involved in various applications of synthetic biology such as biosecurity, gene editing, and exploring the potential of engineering cells for different industries.

• Monthly investor updates are crucial for founders as they build credibility, keep investors informed about progress and challenges, and provide an opportunity for collaboration and support.